ArticleNeoplasia (New York, N.Y.)2020

Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma.

Christopher S Koivisto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.